OWLT.NYSEOwlet, INC

8-K/A: Owlet Exchanges Warrants for Common Stock

Sentiment:

Amendment to Current Report


Owlet, Inc. enters into a privately negotiated agreement to exchange outstanding warrants for newly issued Class A Common Stock, aiming to simplify its capital structure.

Summary

  • Owlet, Inc. (the Company) entered into a privately negotiated Exchange Agreement with certain holders of its Series A and Series B Warrants.
  • Holders will exchange Series A Warrants representing 7,215,737 shares and Series B Warrants representing 1,799,021 shares.
  • In return, the Company will issue an aggregate of 5,426,429 newly issued shares of Class A Common Stock.
  • The valuation of the Warrants for the exchange was determined using a Black-Scholes option pricing model, based on the trailing 60-day volume-weighted average price of the Company's Common Stock as of August 1, 2025, and the Common Stock's realized volatility.
  • The transaction was approved by a special committee of the Board of Directors, consisting solely of disinterested and independent directors.
  • Consummation of the exchanges is subject to stockholder approval in accordance with Section 312.03 of the New York Stock Exchange Listed Company Manual.
  • Key holders involved include Eclipse Ventures LLC (affiliated with Board Chairman Lior Susan), Trilogy Equity Partners, LLC (affiliated with Board member Amy McCullough), CEO Kurt Workman, and Board member John Kim.
  • Holders have agreed to a 180-day lock-up period for the newly issued shares, with limited exceptions.
  • The Company will file a shelf registration statement for the resale of the exchanged shares within 30 days after closing, aiming for effectiveness within 60-90 days.
  • Holders have agreed to vote all beneficially owned Company Voting Securities in favor of the Exchanged Shares Proposal at the 2025 Annual Meeting.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While there is immediate dilution from the issuance of new shares, the transaction aims to simplify the capital structure by eliminating outstanding warrants, which could be seen as a long-term positive for financial clarity and reducing future overhang. The approval by an independent special committee and the requirement for stockholder approval also add a layer of governance and transparency.

Positives

  • Simplifies the Company's capital structure by converting warrants into common stock, potentially reducing future overhang.
  • The transaction was approved by a special committee of disinterested and independent directors, indicating a governance-focused approach.
  • The use of a Black-Scholes model for valuation suggests a market-based and objective approach to pricing the exchange.
  • The 180-day lock-up period for exchanged shares provides some stability post-transaction, limiting immediate selling pressure from these shares.

Negatives

  • The issuance of 5,426,429 new shares of Class A Common Stock will result in dilution for existing shareholders.
  • A significant portion of the exchanged shares are going to related parties, including major investors, the CEO, and Board members, which could raise questions about potential conflicts of interest, despite Special Committee approval.
  • The transaction is contingent on stockholder approval, introducing uncertainty regarding its consummation.

Risks

  • Inability to close the proposed Exchanges due to the failure to obtain Stockholder Approval of the Exchanged Shares Proposal.
  • Failure to satisfy other customary closing conditions set forth in the Exchange Agreement.
  • Potential for a Material Adverse Effect on the Company's business, financial condition, or results of operations, as defined in the agreement, which could prevent or delay the consummation of the exchange.

Future Outlook

The Company expects to consummate the warrant exchanges, which are subject to stockholder approval at the 2025 Annual Meeting. Following closing, the Company plans to file a shelf registration statement within 30 days to allow for the resale of the newly issued shares, aiming for effectiveness within 60-90 days.

Management Comments

  • The Exchange Agreement and the transactions contemplated thereby were approved by a special committee of the Company's board of directors, consisting solely of disinterested and independent directors.

Industry Context

This transaction represents a capital structure optimization move, common for companies seeking to simplify their balance sheets and reduce potential future dilution from outstanding warrants. It aligns with a broader trend of companies managing their equity and debt instruments to improve financial clarity and investor appeal.

Comparison to Industry Standards

  • The use of a Black-Scholes option pricing model for warrant valuation is a standard and widely accepted financial methodology in the industry for valuing options and warrants.
  • The requirement for stockholder approval for significant equity issuances, especially those involving related parties, is consistent with corporate governance best practices and New York Stock Exchange listing rules (Section 312.03).
  • The inclusion of a lock-up period (180 days) for newly issued shares is a common practice in private placements and capital restructuring to prevent immediate selling pressure and provide market stability.
  • Providing registration rights for the resale of privately placed shares is standard practice to ensure liquidity for investors, particularly institutional ones, and is comparable to similar agreements seen in other public companies' capital raises or restructurings.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive Officer and Board MemberNAKurt WorkmanNAIdentified as a holder participating in the warrant exchange, not a change in role.
Board MemberNAJohn KimNAIdentified as a holder participating in the warrant exchange, not a change in role.
Chairman of the BoardNALior SusanNAAffiliated with Eclipse Ventures LLC, a holder participating in the warrant exchange, not a change in role.
Board MemberNAAmy McCulloughNAAffiliated with Trilogy Equity Partners, LLC, a holder participating in the warrant exchange, not a change in role.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Approval ProcessThe Exchange Agreement and contemplated transactions were approved by a special committee of the Company's board of directors, consisting solely of disinterested and independent directors under Delaware law.August 7, 2025Enhances governance and reduces potential conflicts of interest by ensuring independent oversight of the transaction.
Stockholder Approval RequirementConsummation of the Exchanges is subject to stockholder approval in accordance with Section 312.03 of the New York Stock Exchange Listed Company Manual.NAEnsures transparency and accountability to shareholders for significant equity issuances, particularly those involving related parties.

Related Party Transactions

  • Eclipse Ventures LLC, an entity affiliated with Lior Susan (Chairman of the Board), will receive 3,898,906 shares of Common Stock in the Exchanges.
  • Trilogy Equity Partners, LLC, whose President and Managing Director is Amy McCullough (a member of the Board), will receive 686,469 shares of Common Stock in the Exchanges.
  • Kurt Workman, the Company's Chief Executive Officer and member of the Board, will receive 80,235 shares of Common Stock in the Exchanges.
  • John Kim, a member of the Board, will receive 107,626 shares of Common Stock in the Exchanges.
  • Other material relationships between such Holders and the Company are described under 'Certain Relationships and Related Party Transactions' in the Company's Annual Report on Form 10-K/A, filed April 30, 2025.

Stakeholder Impact

  • **Shareholders:** Will experience dilution from the issuance of new shares, but the transaction aims to simplify the capital structure and remove potential overhang from warrants. The requirement for stockholder approval provides a mechanism for shareholders to voice their opinion.
  • **Warrant Holders (participating):** Will convert their warrants into common stock, gaining immediate equity ownership, subject to a 180-day lock-up period, and benefit from registration rights for future liquidity.
  • **Company:** Benefits from a simplified capital structure and potentially reduced future uncertainty regarding warrant exercise, but incurs costs associated with the exchange and registration.

Next Steps

  • Company to include a proposal for stockholder approval of the Exchanged Shares in the proxy statement for its 2025 annual stockholder meeting.
  • Company to file a preliminary proxy statement relating to the 2025 Annual Meeting as promptly as possible, but no later than 30 days after August 7, 2025.
  • Company to file a definitive proxy statement relating to the 2025 Annual Meeting no later than 10 days after SEC review completion.
  • Company to hold the 2025 Annual Meeting promptly following the mailing of the definitive proxy statement.
  • If closing does not occur by November 5, 2025, either the Company or Majority Holders may terminate the Exchange Agreement.
  • As promptly as reasonably practicable after the closing, but within 30 days, the Company will file a shelf registration statement to register the resale of all Exchanged Shares.
  • Company to use commercially reasonable efforts to cause the shelf registration statement to become effective within 60 days (or 90 days if SEC reviews) following the Closing Date.

Key Dates

DateDescription
2023-02-01Approximate date Series A Convertible Preferred Stock and associated warrants were initially issued.
2024-02-01Approximate date Series B Convertible Preferred Stock and associated warrants were initially issued.
2024-12-31Fiscal year end for the Company's Annual Report on Form 10-K.
2025-03-11Date of filing of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024.
2025-03-31Fiscal quarter end for the Company's Quarterly Report on Form 10-Q.
2025-04-30Date of filing of the Company's Annual Report on Form 10-K/A, referenced for related party transactions.
2025-05-19Date of Form 4 filed by Jonathan Harris, reflecting changes in holdings of Owlet securities by directors and executive officers.
2025-06-30Quarterly period end for which the full text of the Exchange Agreement will be filed with the Company's Quarterly Report on Form 10-Q.
2025-08-01Date as of which the trailing 60-day volume-weighted average price of the Common Stock was used for warrant valuation.
2025-08-07Date of entry into the privately negotiated Exchange Agreement and filing of the Original 8-K.
2025-08-13Date of filing of the Current Report on Form 8-K/A (Amendment No. 1).
2025-11-05Outside Date by which the closing of the Exchanges must occur, or either the Company or Majority Holders may terminate the Exchange Agreement.

Recommendation

hold

This filing details a capital structure adjustment rather than a direct operational or financial performance update. While it involves dilution, it also aims to simplify the company's capital structure by converting warrants into common stock, which can be a long-term positive by reducing future overhang. The transaction's approval by an independent special committee and the requirement for shareholder approval suggest a considered approach. Investors should monitor the outcome of the shareholder vote and the company's ongoing business performance, as this transaction alone does not fundamentally alter the investment thesis but rather cleans up the cap table.

Keywords

Owlet, OWLT, Warrant Exchange, Common Stock, Capital Structure, SEC Filing, Corporate Governance, Dilution, Black-Scholes, NYSE, Related Party Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.